The prevention and mitigation of infectious diseases through vaccines remains one of the most revolutionary developments in medicines. While our arsenal comprises vaccines for many childhood and adult diseases, new and innovative research and manufacturing methods are required to achieve the development of innovative vaccines.
This session will discuss the unique research and development challenges for infectious disease vaccines. Panelists will share the potential impact of novel technologies like adjuvants, new expression systems and potential breakthroughs in vaccinology. Panelists will also discuss how companies of all sizes can better link with each other and other organizations around the globe to conquer that next set of diseases.
Session ID: 36183